- Home
- JAGX vs PVBC Comparison
JAGX vs PVBC Comparison
Compare JAGX & PVBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAGX
- PVBC
- Stock Information
- Founded
- JAGX 2013
- PVBC 1913
- Country
- JAGX United States
- PVBC United States
- Employees
- JAGX 49
- PVBC N/A
- Industry
- JAGX Biotechnology: Pharmaceutical Preparations
- PVBC Major Banks
- Sector
- JAGX Health Care
- PVBC Finance
- Exchange
- JAGX Nasdaq
- PVBC Nasdaq
- Market Cap
- JAGX 3.1M
- PVBC N/A
- IPO Year
- JAGX N/A
- PVBC 2015
- Fundamental
- Price
- JAGX $4.85
- PVBC $11.66
- Analyst Decision
- JAGX
- PVBC Hold
- Analyst Count
- JAGX 0
- PVBC 1
- Target Price
- JAGX N/A
- PVBC $12.00
- AVG Volume (30 Days)
- JAGX 37.8K
- PVBC 21.8K
- Earning Date
- JAGX 03-31-2025
- PVBC 04-24-2025
- Dividend Yield
- JAGX N/A
- PVBC N/A
- EPS Growth
- JAGX N/A
- PVBC N/A
- EPS
- JAGX N/A
- PVBC 0.43
- Revenue
- JAGX $11,689,000.00
- PVBC $55,400,000.00
- Revenue This Year
- JAGX $18.18
- PVBC $13.23
- Revenue Next Year
- JAGX $40.06
- PVBC $6.83
- P/E Ratio
- JAGX N/A
- PVBC $26.70
- Revenue Growth
- JAGX 19.75
- PVBC N/A
- 52 Week Low
- JAGX $4.41
- PVBC $7.36
- 52 Week High
- JAGX $540.00
- PVBC $12.96
- Technical
- Relative Strength Index (RSI)
- JAGX 20.48
- PVBC 50.98
- Support Level
- JAGX $4.41
- PVBC $11.32
- Resistance Level
- JAGX $5.45
- PVBC $12.00
- Average True Range (ATR)
- JAGX 0.95
- PVBC 0.37
- MACD
- JAGX 0.00
- PVBC 0.02
- Stochastic Oscillator
- JAGX 3.54
- PVBC 46.53
About JAGX Jaguar Health Inc.
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.